loadpatents
name:-0.00038599967956543
name:-0.021186828613281
name:-0.00048112869262695
Hellstrom; Karl E. Patent Filings

Hellstrom; Karl E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hellstrom; Karl E..The latest application filed is for "antibodies to her4, human receptor tyrosine kinase".

Company Profile
0.20.0
  • Hellstrom; Karl E. - Seattle WA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies to HER4, human receptor tyrosine kinase
Grant 5,811,098 - Plowman , et al. September 22, 1
1998-09-22
Tumor immunotherapy using anti-idiotypic antibodies
Grant 5,614,610 - Hellstrom , et al. March 25, 1
1997-03-25
Tumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their use
Grant 5,597,707 - Marken , et al. January 28, 1
1997-01-28
Monoclonal antibody BR 96 and chimeric monoclonal antibodies having the variable region of MAB BR96, which bind to a variant of ley antigen on human carcimona cells
Grant 5,491,088 - Hellstrom , et al. February 13, 1
1996-02-13
Chimeric antibody with specificity to human tumor antigen
Grant 5,354,847 - Liu , et al. October 11, 1
1994-10-11
Recombinant viruses encoding the human melanoma-associated antigen
Grant 5,262,177 - Brown , et al. November 16, 1
1993-11-16
Monoclonal antibody to human carcinomas
Grant 5,242,824 - Hellstrom , et al. September 7, 1
1993-09-07
Monoclonal antibody to novel antigen associated with human tumors
Grant 5,171,665 - Hellstrom , et al. December 15, 1
1992-12-15
Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
Grant 5,165,922 - Hellstrom , et al. November 24, 1
1992-11-24
Vaccines against melanoma
Grant 5,141,742 - Brown , et al. August 25, 1
1992-08-25
Monoclonal antibody to novel antigen associated with human tumors
Grant 5,134,075 - Hellstrom , et al. July 28, 1
1992-07-28
Monoclonal antibodies for treatment of human non-small cell lung carcinomas
Grant 5,091,177 - Hellstrom , et al. February 25, 1
1992-02-25
Tumor therapy with biologically active anti-tumor antibodies
Grant 5,091,178 - Hellstrom , et al. February 25, 1
1992-02-25
Immunoconjugates and methods for their use in tumor therapy
Grant 5,084,560 - Hellstrom , et al. January 28, 1
1992-01-28
pH-sensitive immunoconjugates and methods for their use in tumor therapy
Grant 4,997,913 - Hellstrom , et al. March 5, 1
1991-03-05
Monoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomas
Grant 4,935,495 - Hellstrom , et al. June 19, 1
1990-06-19
Tumor immunotherapy using anti-idiotypic antibodies
Grant 4,918,164 - Hellstrom , et al. April 17, 1
1990-04-17
Monocolonal antibodies and antigen for human non-small cell lung carcinomas
Grant 4,906,562 - Hellstrom , et al. March 6, 1
1990-03-06
Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies
Grant 4,873,188 - Hellstrom , et al. October 10, 1
1989-10-10
Monoclonal antibodies for human non-small cell lung carinomas
Grant 4,737,579 - Hellstrom , et al. April 12, 1
1988-04-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed